Search Results
You are looking at 1 - 3 of 3 items for
- Author: Mark Craighead x
- Refine by access: All content x
Search for other papers by Francesca Spiga in
Google Scholar
PubMed
Search for other papers by Louise R Harrison in
Google Scholar
PubMed
Search for other papers by Susan A Wood in
Google Scholar
PubMed
Search for other papers by Cliona P MacSweeney in
Google Scholar
PubMed
Search for other papers by Fiona J Thomson in
Google Scholar
PubMed
Search for other papers by Mark Craighead in
Google Scholar
PubMed
Search for other papers by Morag Grassie in
Google Scholar
PubMed
Search for other papers by Stafford L Lightman in
Google Scholar
PubMed
We investigated the effect of the glucocorticoid receptor (GR) antagonist Org 34850 on fast and delayed inhibition of corticosterone secretion in response to the synthetic glucocorticoid methylprednisolone (MPL). Male rats were implanted with a catheter in the right jugular vein, for blood sampling and MPL administration, and with an s.c. cannula for Org 34850 administration. All experiments were conducted at the diurnal hormonal peak in the late afternoon. Rats were connected to an automated sampling system and blood samples were collected every 5 or 10 min. Org 34850 (10 mg/kg, s.c.) or vehicle (5% mulgofen in saline) was injected at 1630 h; 30 min later, rats received an injection of MPL (500 μg/rat, i.v.) or saline (0.1 ml/rat). We found that an acute administration of MPL rapidly decreased the basal corticosterone secretion and this effect was not prevented by acute pretreatment with Org 34850. However, blockade of GR with Org 34850 prevented delayed inhibition of MPL on corticosterone secretion measured between 4 and 12 h after MPL administration. Our data suggest an involvement of GR in modulating delayed, but not fast, inhibition induced by MPL on basal corticosterone secretion.
Search for other papers by Francesca Spiga in
Google Scholar
PubMed
Search for other papers by Louise R Harrison in
Google Scholar
PubMed
Search for other papers by Susan Wood in
Google Scholar
PubMed
Search for other papers by David M Knight in
Google Scholar
PubMed
Search for other papers by Cliona P MacSweeney in
Google Scholar
PubMed
Search for other papers by Fiona Thomson in
Google Scholar
PubMed
Search for other papers by Mark Craighead in
Google Scholar
PubMed
Search for other papers by Stafford L Lightman in
Google Scholar
PubMed
Vasopressin (AVP), produced in parvocellular neurons of the hypothalamic paraventricular nucleus, regulates, together with CRH, pituitary ACTH secretion. The pituitary actions of AVP are mediated through the G protein receptor V1b (V1b|R). In man, hyperactivity of the hypothalamic–pituitary–adrenal axis has been associated with depression and other stress-related conditions. There are also clinical data suggesting a role for AVP in the dysfunctional HPA axis described in some depressed patients. In this study, we have investigated the effect of a recently synthesised selective antagonist of the V1bR both on exogenous AVP-induced ACTH and corticosterone secretion, and on basal and stress-induced pituitary–adrenal activity. Adult male Sprague-Dawley rats treated with the V1bR antagonist (Org, 30 mg/kg, s.c.) or vehicle (5% mulgofen in 0.9% saline, 2 ml/kg, s.c.). We found that blockade of the V1bR reduced the increase in both ACTH and corticosterone secretion induced by AVP (100 ng, i.v.). The same treatment had no effect either on basal ACTH and corticosterone levels or on the ultradian or diurnal rhythms of corticosterone secretion. Acute administration of the V1bR antagonist reduced ACTH secretion following both restraint and lipopolysaccharide, but did not antagonise the ACTH response to noise. The same treatment did not reduce corticosterone secretion in response to any of the three stressors used in this study. Our results confirm that this compound is an antagonist of the V1bR in the rat, and that its ability to reduce stress-induced ACTH responses is stressor dependent with differential modulation of pituitary and adrenal responses.
Search for other papers by Francesca Spiga in
Google Scholar
PubMed
Search for other papers by Louise R Harrison in
Google Scholar
PubMed
Search for other papers by Cliona P MacSweeney in
Google Scholar
PubMed
Search for other papers by Fiona J Thomson in
Google Scholar
PubMed
Search for other papers by Mark Craighead in
Google Scholar
PubMed
Search for other papers by Stafford L Lightman in
Google Scholar
PubMed
Exposure to chronic restraint (CR) modifies the hypothalamic–pituitary–adrenal (HPA) axis response to subsequent acute stressors with adaptation of the response to a homotypic and sensitization of the response to a heterotypic stressor. Since vasopressin (AVP) activity has been reported to change during chronic stress, we investigated whether this was an important factor in HPA facilitation. We therefore tested whether vasopressin 1b receptor (AVPR1B) blockade altered the ACTH and corticosterone response to heterotypic stressors following CR stress. Adult male rats were exposed to CR, single restraint, or were left undisturbed in the home cage. Twenty-four hours after the last restraint, rats were injected with either a AVPR1B antagonist (Org, 30 mg/kg, s.c.) or vehicle (5% mulgofen in saline, 0.2/kg, s.c.) and then exposed to either restraint, lipopolysaccharide (LPS) or white noise. CR resulted in the adaptation of the ACTH and corticosterone response to restraint and this effect was not prevented by pretreatment with Org. Although we found no effect of CR on LPS-induced ACTH and corticosterone secretion, both repeated and single episodes of restraint induced the sensitization of the ACTH, but not corticosterone response to acute noise. Pretreatment with Org reduced the exaggerated ACTH response to noise after both single and repeated exposure to restraint.